![]() |
市场调查报告书
商品编码
1813378
2032 年超音波手术刀市场预测:按产品、可用性、应用、最终用户和地区进行的全球分析Ultrasonic Scalpel Market Forecasts to 2032 - Global Analysis By Product, Usability, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球超音波手术刀市场预计在 2025 年达到 25.1 亿美元,到 2032 年将达到 47.5 亿美元,预测期内的复合年增长率为 9.5%。
超音波手术刀是一种利用高频超音波振动同时切割和凝固组织的手术器械。其工作原理是将电能转化为机械运动,产生快速的刀片振动,并透过摩擦产生局部热量。这不仅能实现精确解剖,还能最大限度地减少对周围组织的热损伤。超音波手术刀常用于腹腔镜和开放性手术,能够改善止血效果、减少出血并提高手术区域的可视性,使其成为现代微创手术中的重要工具。
微创手术(MIS)的需求不断增加
超音波手术刀正成为各专业微创手术方案的重要组成部分,能够以最小的热损伤实现精确的组织解剖。随着手术效果的改善以及医疗系统寻求降低手术成本,对超音波手术刀等先进能量器材的需求持续飙升。随着人们日益重视以患者为中心的照护以及手术器械技术的进步,这一趋势进一步加剧。这些技术可以减轻术后疼痛、缩短住院时间并加快復健速度,对患者和医疗机构都极具吸引力。
替代手术技术的可用性
在某些外科手术情况下,超音波手术刀的替代技术具有显着优势,这可能会限制超音波解决方案的普及。此外,医院和手术中心在选择设备时,通常优先考虑成本效益以及与现有基础设施的兼容性,这可能会阻碍其市场渗透。此外,集切割、凝固和封闭功能于一体的多功能设备的出现,也对独立超音波系统构成了挑战。
门诊手术中心的兴起
ASC 优先考虑效率、成本控制和微创手术,这与超音波设备的功能高度契合。这些中心越来越多地在传统医院环境之外进行复杂的手术,这推动了对紧凑、可靠且易于使用的设备的需求。此外,优惠的报销政策和对门诊护理的监管支持正在鼓励对先进外科技术的投资。随着 ASC 数量和规模的不断扩大,这为製造商扩大市场覆盖范围并为高通量环境客製化解决方案提供了重要机会。
供应链中断与贸易政策
全球供应链的不稳定和不断变化的贸易政策给超音波手术刀市场带来了重大风险。购买专用零件(包括压电材料和精密加工的刀片)容易受到延误和成本波动的影响。地缘政治紧张局势、出口管制和监管变化可能会进一步加剧国际分销和製造业务的复杂性。此外,依赖第三方供应商提供关键零件会增加品管问题和物流瓶颈的风险。
新冠疫情对超音波手术刀市场产生了双重影响,最初扰乱了手术量和供应链,但随后加速了向微创手术的转变。在疫情高峰期,择期手术被推迟,导致器械利用率暂时下降。然而,随着医疗体系的调整,人们重新重视高效、低风险的手术,并青睐超音波手术刀等能够缩短手术时间、减少术后併发症的技术。疫情也凸显了感染控制的重要性,促使医院投资支持精准和安全的先进工具。
超音波手术刀系统预计将成为预测期内最大的细分市场
超音波手术刀系统凭藉其多功能性和临床有效性,预计将在预测期内占据最大的市场份额。超音波手术刀系统凭藉其卓越的切割和凝固能力,成为从一般外科到肿瘤外科等各种手术的必备工具。其能够最大限度地减少组织损伤和失血,从而改善手术效果,并因此被广泛采用。人体工学设计、能量调节以及刀片技术的不断创新,进一步提升了其吸引力。
预计预测期内整形外科的复合年增长率最高
预计整形外科领域将在预测期内实现最高成长率,这反映了骨骼和软组织手术对精密工具日益增长的需求。超音波手术刀因其能够实现干净的切割且热损伤最小,在关节重建、脊椎手术和创伤治疗中的应用日益广泛。肌肉骨骼疾病的增加、人口老化以及运动相关伤害正在推动整形外科手动手术的增加。此外,超音波技术与机器人技术和导航系统的结合提高了手术精度,使其成为骨科医生的首选。
预计北美将在预测期内占据最大的市场份额,这得益于其先进的医疗基础设施、较高的手术量以及主要行业参与者的强大影响力。该地区受益于创新外科技术的早期采用以及对研发的大力投入。优惠的报销框架和严格的监管标准也推动了器械部署的品质和安全。此外,癌症和心血管疾病等需要外科手术介入的慢性疾病的发生率不断上升,也支撑了超音波手术刀的持续需求。
预计亚太地区将在预测期内实现最高的复合年增长率,这得益于医疗保健覆盖面的扩大、手术需求的不断增长以及政府主导的现代化倡议。中国、印度和韩国等国家在医疗旅游业蓬勃发展和基础设施改善的推动下,微创手术正在快速成长。本土製造商正凭藉经济高效的解决方案进入市场,而跨国公司则正在投资建立区域合作伙伴关係,以发掘新的商机。老化和都市化等人口趋势也推动了手术数量的成长。
According to Stratistics MRC, the Global Ultrasonic Scalpel Market is accounted for $2.51 billion in 2025 and is expected to reach $4.75 billion by 2032 growing at a CAGR of 9.5% during the forecast period. Ultrasonic scalpel is a surgical instrument that utilizes high-frequency ultrasonic vibrations to simultaneously cut and coagulate tissue. It operates by converting electrical energy into mechanical motion, producing rapid blade oscillations that generate localized heat through friction. This enables precise dissection with minimal thermal damage to surrounding structures. Commonly used in laparoscopic and open procedures, ultrasonic scalpels offer improved hemostasis, reduced blood loss, and enhanced visibility in the surgical field, making them valuable tools in modern minimally invasive surgery.
Growing demand for minimally invasive surgeries (MIS)
Ultrasonic scalpels, which enable precise tissue dissection with minimal thermal damage, are becoming integral to MIS protocols across specialties. As surgical outcomes improve and healthcare systems aim to lower procedural costs, demand for advanced energy-based instruments like ultrasonic scalpels continues to surge. The trend is further supported by growing awareness of patient-centric care and technological advancements in surgical instrumentation. These techniques offer reduced post-operative pain, shorter hospital stays, and faster recovery times, making them highly attractive to both patients and healthcare providers.
Availability of alternative surgical technologies
Ultrasonic Scalpel alternatives offer distinct benefits in specific surgical contexts, potentially limiting the adoption of ultrasonic solutions. Moreover, hospitals and surgical centers often weigh cost-effectiveness and compatibility with existing infrastructure when selecting equipment, which can hinder market penetration. The availability of multifunctional devices that combine cutting, coagulation, and sealing capabilities also poses a challenge to standalone ultrasonic systems.
Growing number of ambulatory surgery centers
ASCs prioritize efficiency, cost control, and minimally invasive procedures, aligning well with the capabilities of ultrasonic devices. These centers are increasingly performing complex surgeries outside traditional hospital settings, driving demand for compact, reliable, and easy-to-use instruments. Additionally, favorable reimbursement policies and regulatory support for outpatient care are encouraging investment in advanced surgical technologies. As ASCs continue to grow in number and scope, they represent a significant opportunity for manufacturers to expand their market footprint and tailor solutions for high-throughput environments.
Supply chain disruptions and trade policies
Global supply chain instability and evolving trade policies pose notable risks to the ultrasonic scalpel market. The sourcing of specialized components, including piezoelectric materials and precision-engineered blades, is susceptible to delays and cost fluctuations. Geopolitical tensions, export restrictions, and regulatory changes can further complicate international distribution and manufacturing operations. In addition, reliance on third-party suppliers for critical parts increases exposure to quality control issues and logistical bottlenecks.
The COVID-19 pandemic had a dual impact on the ultrasonic scalpel market, initially disrupting surgical volumes and supply chains, but later accelerating the shift toward minimally invasive procedures. Elective surgeries were postponed during peak infection periods, leading to a temporary decline in device utilization. However, as healthcare systems adapted, there was renewed emphasis on efficient, low-risk surgical interventions favoring technologies like ultrasonic scalpels that reduce operating time and post-operative complications. The pandemic also underscored the importance of infection control, prompting hospitals to invest in advanced tools that support precision and safety.
The ultrasonic scalpel systems segment is expected to be the largest during the forecast period
The ultrasonic scalpel systems segment is expected to account for the largest market share during the forecast period driven by its versatility and clinical efficacy. These systems offer superior cutting and coagulation performance, making them indispensable in procedures ranging from general surgery to oncology. Their ability to minimize collateral tissue damage and reduce blood loss enhances surgical outcomes, contributing to widespread adoption. Continuous innovation in ergonomic design, energy modulation, and blade technology is further strengthening their appeal.
The orthopedic surgery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the orthopedic surgery segment is predicted to witness the highest growth rate reflecting growing demand for precision tools in bone and soft tissue procedures. Ultrasonic scalpels are increasingly used in joint replacement, spinal surgery, and trauma care due to their ability to perform clean cuts with minimal thermal injury. The rise in musculoskeletal disorders, aging populations, and sports-related injuries is fueling procedural volumes in orthopedics. Moreover, the integration of ultrasonic technology with robotic and navigation systems is enhancing surgical accuracy, making it a preferred choice among orthopedic surgeons.
During the forecast period, the North America region is expected to hold the largest market share owing to its advanced healthcare infrastructure, high surgical volumes, and strong presence of key industry players. The region benefits from early adoption of innovative surgical technologies and robust investment in research and development. Favorable reimbursement frameworks and stringent regulatory standards also drive quality and safety in device deployment. Additionally, the growing prevalence of chronic conditions requiring surgical intervention such as cancer and cardiovascular diseases supports sustained demand for ultrasonic scalpels.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR propelled by expanding healthcare access, rising surgical demand, and government-led modernization initiatives. Countries like China, India, and South Korea are witnessing rapid growth in minimally invasive procedures, supported by increasing medical tourism and infrastructure development. Local manufacturers are entering the market with cost-effective solutions, while global players are investing in regional partnerships to tap into emerging opportunities. The region's demographic trends, including aging populations and urbanization, are contributing to higher surgical caseloads.
Key players in the market
Some of the key players in Ultrasonic Scalpel Market include Johnson & Johnson, Medtronic plc, Olympus Corporation, Stryker Corporation, Misonix Inc., BOWA-electronic GmbH & Co. KG, Axon Medical Solutions, Wuhan BBT Medical Tech Co., Ltd., Reach Surgical Inc., Innolcon Medical Technology, InnoSound Technologies Inc., Heal Force Bio-Meditech Holdings, DePuy Synthes (J&J), ConMed Corporation, NSK Ltd., and Boston Scientific Corporation.
In July 2025, Innolcon completed pilot production of ultrasonic scalpels at its Hefei facility. This milestone supports domestic innovation in energy-based surgical systems. It reflects Innolcon's expansion into ophthalmic and laparoscopic robotics.
In April 2025, Axon unveiled new fixed license plate recognition cameras and AI-powered safety tools. These additions expand its real-time public safety ecosystem. The launch supports drone integration and automated alerts.
In January 2025, BBT Medical acquired a distribution business in Chile to expand its LATAM footprint. The move strengthens its minimally invasive surgical systems portfolio. It aligns with BBT's global strategy for ultrasonic and RF platforms.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.